These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 16019945
1. Metabolism and excretion of loratadine in male and female mice, rats and monkeys. Ramanathan R, Alvarez N, Su AD, Chowdhury S, Alton K, Stauber K, Patrick J. Xenobiotica; 2005 Feb; 35(2):155-89. PubMed ID: 16019945 [Abstract] [Full Text] [Related]
4. Metabolism of loratadine and further characterization of its in vitro metabolites. Ghosal A, Gupta S, Ramanathan R, Yuan Y, Lu X, Su AD, Alvarez N, Zbaida S, Chowdhury SK, Alton KB. Drug Metab Lett; 2009 Aug; 3(3):162-70. PubMed ID: 19702548 [Abstract] [Full Text] [Related]
12. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites. Prakash C, Cui D. Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030 [Abstract] [Full Text] [Related]
14. Metabolism and excretion of RWJ-333369 [1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (S)-] in mice, rats, rabbits, and dogs. Mamidi RN, Mannens G, Annaert P, Hendrickx J, Goris I, Bockx M, Janssen CG, Kao M, Kelley MF, Meuldermans W. Drug Metab Dispos; 2007 Apr; 35(4):566-75. PubMed ID: 17220243 [Abstract] [Full Text] [Related]
15. Biotransformation of carbon-14-labeled muraglitazar in male mice: interspecies difference in metabolic pathways leading to unique metabolites. Li W, Zhang D, Wang L, Zhang H, Cheng PT, Zhang D, Everett DW, Humphreys WG. Drug Metab Dispos; 2006 May; 34(5):807-20. PubMed ID: 16467134 [Abstract] [Full Text] [Related]
16. Disposition and metabolism of olanzapine in mice, dogs, and rhesus monkeys. Mattiuz E, Franklin R, Gillespie T, Murphy A, Bernstein J, Chiu A, Hotten T, Kassahun K. Drug Metab Dispos; 1997 May; 25(5):573-83. PubMed ID: 9152596 [Abstract] [Full Text] [Related]
20. Metabolism, excretion, and pharmacokinetics of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid, an EP2 receptor-selective prostaglandin E2 agonist, in male and female Sprague-Dawley rats. Johnson KA, Prakash C. Drug Metab Dispos; 2005 Aug; 33(8):1191-201. PubMed ID: 15886349 [Abstract] [Full Text] [Related] Page: [Next] [New Search]